2024- TPA Dosage Forms list

2024- TPA Dosage Forms list
Product Description

Connecting Taiwan's pharmaceutical manufacturers with the global marketplace through various business models such as In-Out Licensing, Tech-Transfer, Contract Manufacturing Organization (CMO), and Contract Development and Manufacturing Organization (CDMO). We collaborate closely not only with local manufacturers but also with the Taiwan FDA to address regulatory challenges and ensure compliance. For more information, please contact [email protected]

Taiwan Pharmaceutical Alliance

  • Country/Region:
    Taiwan
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
OTC
Pharmaceutical Company (generic finished products)

Taiwan Pharmaceutical Alliance

  • Country/Region:
    Taiwan
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Contract Service
Distributor/Import Export
Licensee
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
OTC
Pharmaceutical Company (generic finished products)

More Products from Taiwan Pharmaceutical Alliance (6)

  • 2024- TPA Brochure
  • 2024- TPA Overview

    Product 2024- TPA Overview

    Product types covered by TPA members-Download our brochure or Contact [email protected] for more information.
  • 2025 OEP group product list

    Product 2025 OEP group product list

    all Taiwan OEP product list
  • 2025 TPA Brochure

    Product 2025 TPA Brochure

    Taiwan Pharmaceutical Alliance is comprised of Taiwan Top pharmaceutical companies, where there are specialised in diffferent fields. TPA members include PICS/GMP certified manufacturers with proven expertise across a wide range of dosage forms- including oral solids, liquids, MDIs/ DPIs. injectables, nasa...
  • 2026 TPA Brochure

    Product 2026 TPA Brochure

    TPA unites 24 Taiwan pharmaceutical companies at  least with diverse expertise in products and dosage forms.We provide end-to-end solutions, from drug R&D and clinical trials to finished product manufacturing, with advanced technologies including hot-melt extrusion, nano-grinding, contin...
  • 2026 TPA-Services

    Product 2026 TPA-Services

    Each member of our network has different areas of expertise and offers a broad range of dosage form manufacturing and development services. Our partners hold approvals and certifications from major global regulatory authorities, including the US FDA, Japan PMDA, UK MHRA, EU GMP, and others.

    We a...

Taiwan Pharmaceutical Alliance resources (7)

  • News Taiwan Pharmaceutical will be exhibiting in CPHI Milan

    CPHI Milan is THE place to spark new ideas, forge meaningful connections, and shape the future of Pharma, and we are excited to announce TPA's exhibitions at CPHI Milan this year. Our booth is No. 8J7. 

  • Brochure 2026 TPA Brochure

    Taiwan Pharmaceutical Alliance (TPA) unites 24 Taiwan pharmaceutical companies at  least with diverse expertise in products and dosage forms.

    We provide end-to-end solutions, from drug R&D and clinical trials to finished product manufacturing, with advanced technologies including hot-melt extrusion, nano-grinding, continuous manufacturing, LAIs, OROS, and PFS.Our members comply with PIC/S GMP standards and have successfully passed inspections by the U.S. FDA, PMDA, EMA, and MENA authorities, demonstrating our commitment to quality and reliable supply.We are seeking international partners to explore global opportunities together. 

    We would be delighted to meet you at CPHI Milan and discuss potential collaboration.
  • Video Why TPA is your Best and Trustworthy Partner?

    Taiwan Pharmaceutical Alliance is your trusted pharmaceutical partner in Taiwan, offering high-quality manufacturing capabilities aligned with PIC/S GMP standards.

    Our members provide diverse expertise in specialized dosage forms, technologies, and production capacities, delivering flexible and customized solutions for global pharmaceutical needs. We also support partners in building a resilient and reliable pharmaceutical supply chain.

    With extensive export experience and regulatory approvals and inspections across the U.S., Japan, Australia, Europe, the U.K., and the Middle East, our members are well equipped to serve international markets.

    We are actively seeking global partners to build long-term collaborations and create mutual success and win-win opportunities.
  • Brochure TPA-APIs- Yung Zip Chem.

    Yung Zip is proud to be Taiwan’s first GMP-certified API manufacturer and to hold the longest FDA inspection track record in the region. We provide integrated small-molecule solutions from early-stage intermediates to cGMP and commercial API supply. Our end-to-end platform implement seamless scale-up, standardized quality, and regulatory readiness across every development stage—making us a trusted partner for efficient, reliable, and sustainable drug development. 

    We combine deep chemical expertise with efficient-focused execution to help clients move faster, control risk, and advance towards market success with confidence. Seamless tech transfer, optimized process and cost-efficient scale-up solutions are provided.
  • Brochure TPA- OEP Group

    OEP Group is a global science-based company specializing in health, nutrition, pharmaceuticals, and cosmeceuticals. Established in 1982, Orient EuroPharma Co., Ltd. (OEP) has led innovation and became publicly listed on the Taipei Exchange in 2003 (stock code: 4120). To expand its capabilities, OEP founded OrientPHARMA (stock code: 4166) in 2008 and OP NanoPharma in 2014, focusing on new drug development and manufacturing. 

    This vertical integration enhances expertise across pharmaceutical R&D, clinical development, production, and marketing. OEP also provides comprehensive CDMO services at its US FDA and PIC/S GMP-certified facility, specializing in injectable product development, aseptic filling, lyophilization, and analytical services.
     
    With a strong commitment to quality and innovation, OEP Group continues advancing science and healthcare globally, delivering solutions that improve health and well-being.

  • Brochure TPA- UBI Pharma

    UBI Pharma Inc. (UBIP) is one of the leading pharmaceutical companies in Taiwan. UBIP specializes in developing and manufacturing high quality generics and fusion protein drugs, as well as providing contract development and manufacturing services to global clients.

    UBIP's facility is routinely inspected by TFDA, USFDA and PMDA. We are capable of manufacturing finished dosage form of Sterile (Vial, Ampoule and Lyophilized) and Non-Sterlie (Tablet, Capsule, Powder, Cream and Ointment), and have been the contract manufacturer for multiple world renowned pharmaceutical companies for more than 20 years.
    UBIP is also proud of being nominated by the goverment to manufactruring controlled drugs and COVID-19 vaccines.

    UBIP continues to seek global partners to provide High-Quality, Affordable, and Innovative Medicines that help patients lead healthier lives.

  • Brochure Taiwan PBF product list

    Controlled API, Originator new drug for nephrology (Nephoxil & Fexenol) and innovation Aesthetic products